(PDF) A Clinical Study to Assess CYP1A2 and CYP3A4

A Clinical Study to Assess CYP1A2 and CYP3A4 Induction by AZD7325, a Selective GABAA Receptor Modulator - An in Vitro and in Vivo Comparison

British Journal of Clinical Pharmacology - United Kingdom

doi 10.1111/j.1365-2125.2011.04155.x

Full Text

Abstract

Available in full text

Categories

Date

June 11, 2012

Authors

Maria D. Ribadeneira

Publisher

Wiley

Related search

Variation in the Response of Clozapine Biotransformation Pathways in Human Hepatic Microsomes to CYP1A2 and CYP3A4-selective Inhibitors

Basic and Clinical Pharmacology and Toxicology

English

Echinacea Purpureaup-Regulates CYP1A2, CYP3A4 and MDR1 Gene Expression by Activation of Pregnane X Receptor Pathway

English

A Selective Defect in Fas-Mediated Apoptosis in HAM/TSP: An Ex Vivo, in Vitro and in Silico Study

Infectious Diseases

English

In Vitro and in Vivo Pharmacological Models to Assess Demyelination and Remyelination

Neuropsychopharmacology

English

GABAA Receptor Genetics and Clinical Pharmacology

Current Anesthesiology Reports

English

Effects of a Cannabinoid Receptor 2 Selective Antagonist on the Inflammatory Reaction to Titanium Particles in Vivo and in Vitro

Journal of International Medical Research

English

Correction To: Comparison of Flow Estimators for Rotary Blood Pumps: An in Vitro and in Vivo Study

Annals of Biomedical Engineering

Biomedical Engineering

English

GABAA Receptor Dephosphorylation Followed by Internalization Is Coupled to Neuronal Death in in Vitro Ischemia

Neurobiology of Disease

English

A Novel Mechanism of Cocaine to Enhance Dopamine D2-Like Receptor Mediated Neurochemical and Behavioral Effects. An in Vivo and in Vitro Study

Neuropsychopharmacology

English